#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11836	16S	1529	1529	99.93	16S.l15.c17.ctg.2	2296	619.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1712	1712	T	739	T,G,C,A	733,4,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11836	16S	1529	1529	99.93	16S.l15.c17.ctg.2	2296	619.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1446	1446	C	820	C,T	819,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20140	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4111	610.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1891	1891	A	871	A,C,G	867,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20140	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4111	610.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2525	2525	C	664	C,T,A	662,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20140	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4111	610.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3151	3151	T	760	T,G	758,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20140	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4111	610.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2599	2599	A	582	A	582	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1368	folP	852	852	93.78	folP.l15.c4.ctg.1	1913	89.2	0	.	p	.	0	G5V	NONSYN	13	15	GGT	542	544	GTT	107;109;110	G;T;T	107;109;110	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1368	folP	852	852	93.78	folP.l15.c4.ctg.1	1913	89.2	0	.	p	.	0	E12K	NONSYN	34	36	GAA	563	565	AAA	121;125;125	A;A;A	121;125;125	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1368	folP	852	852	93.78	folP.l15.c4.ctg.1	1913	89.2	0	.	p	.	0	F31L	NONSYN	91	93	TTT	620	622	TTG	138;138;137	T;T;G	138;138;137	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1368	folP	852	852	93.78	folP.l15.c4.ctg.1	1913	89.2	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	653	655	CAA	160;159;160	C,A;A;A	159,1;159;160	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1368	folP	852	852	93.78	folP.l15.c4.ctg.1	1913	89.2	0	.	p	.	0	S75P	NONSYN	223	225	TCC	752	754	CCT	175;172;171	C;C;T	175;172;171	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1368	folP	852	852	93.78	folP.l15.c4.ctg.1	1913	89.2	0	.	p	.	0	V87A	NONSYN	259	261	GTA	788	790	GCA	156;155;155	G;C,T;A	156;154,1;155	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1368	folP	852	852	93.78	folP.l15.c4.ctg.1	1913	89.2	0	.	p	.	0	V130L	NONSYN	388	390	GTC	917	919	CTC	162;159;160	C;T;C,T	162;159;158,2	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1368	folP	852	852	93.78	folP.l15.c4.ctg.1	1913	89.2	0	.	p	.	0	R135C	NONSYN	403	405	CGC	932	934	TGT	170;170;170	T,A;G;T,G	169,1;170;169,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1368	folP	852	852	93.78	folP.l15.c4.ctg.1	1913	89.2	0	.	p	.	0	T137A	NONSYN	409	411	ACG	938	940	GCG	170;170;170	G;C;G,T	170;170;169,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1368	folP	852	852	93.78	folP.l15.c4.ctg.1	1913	89.2	0	.	p	.	0	E151K	NONSYN	451	453	GAA	980	982	AAG	182;177;176	A,C;A;G	181,1;177;176	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1368	folP	852	852	93.78	folP.l15.c4.ctg.1	1913	89.2	0	.	p	.	0	T152N	NONSYN	454	456	ACC	983	985	AAT	180;183;184	A,G;A;T	179,1;183;184	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1368	folP	852	852	93.78	folP.l15.c4.ctg.1	1913	89.2	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1181	1183	TTG	113;113;112	T;T;G	113;113;112	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1368	folP	852	852	93.78	folP.l15.c4.ctg.1	1913	89.2	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1211	1213	AGC	95;96;96	A;G;C	95;96;96	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1368	folP	852	852	93.78	folP.l15.c4.ctg.1	1913	89.2	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1280	1282	CTG	101;101;101	C;T,G;G	101;99,2;101	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1368	folP	852	852	93.78	folP.l15.c4.ctg.1	1913	89.2	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1286	1288	TCC	100;101;102	T;C;C	100;101;102	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1368	folP	852	852	93.78	folP.l15.c4.ctg.1	1913	89.2	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1301	1303	GTG	115;115;116	G;T;G	115;115;116	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1368	folP	852	852	93.78	folP.l15.c4.ctg.1	1913	89.2	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1352	1354	GCG	142;140;138	G,T;C;G,T	141,1;140;136,2	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4762	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3812	155.8	1	SNP	p	S91F	0	.	.	271	273	TCC	825	827	TCC	186;187;188	T,C;C;C	185,1;187;188	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4762	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3812	155.8	1	SNP	p	D95N	0	.	.	283	285	GAC	837	839	GAC	196;196;198	G;A;C,A	196;196;197,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4762	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3812	155.8	1	SNP	p	D95G	0	.	.	283	285	GAC	837	839	GAC	196;196;198	G;A;C,A	196;196;197,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	531	1620	mtrR	633	633	99.68	mtrR.l15.c30.ctg.1	1944	103.9	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	1076	1076	T	188	T	188	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	912	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1432	79.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4126	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3627	142.0	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1789	1791	ATC	195;196;196	A;T;C	195;196;196	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4126	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3627	142.0	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1942	1944	GCA	192;190;192	G;C,T;A	192;189,1;192	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4126	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3627	142.0	1	SNP	p	D86N	0	.	.	256	258	GAC	895	897	GAC	195;192;187	G;A;C	195;192;187	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4126	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3627	142.0	1	SNP	p	S87R	0	.	.	259	261	AGT	898	900	AGT	186;184;183	A;G;T,A	186;184;182,1	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4126	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3627	142.0	1	SNP	p	S87W	0	.	.	259	261	AGT	898	900	AGT	186;184;183	A;G;T,A	186;184;182,1	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4126	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3627	142.0	1	SNP	p	S87I	0	.	.	259	261	AGT	898	900	AGT	186;184;183	A;G;T,A	186;184;182,1	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4126	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3627	142.0	1	SNP	p	S88P	0	.	.	262	264	TCC	901	903	TCC	185;186;188	T;C;C	185;186;188	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3660	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3036	150.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1764	1766	GGC	180;180;178	G,C;G;C	179,1;180;178	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	3302	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2981	138.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1559	1561	GCA	196;194;193	G;C,A;A	196;193,1;193	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3302	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2981	138.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1562	1564	ATC	190;188;189	A;T;C,T	190;188;188,1	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3302	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2981	138.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1574	1576	GTG	186;190;191	G,T;T;G,C	185,1;190;190,1	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3302	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2981	138.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1574	1576	GTG	186;190;191	G,T;T;G,C	185,1;190;190,1	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3302	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2981	138.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2078	2080	ACC	184;184;182	A,C;C,A;C	183,1;183,1;182	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3302	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2981	138.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2132	2134	GCG	198;197;199	G;C;G	198;197;199	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3302	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2981	138.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2132	2134	GCG	198;197;199	G;C;G	198;197;199	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3302	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2981	138.1	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2255	2257	GGT	201;201;198	G,T;G,T;T	200,1;200,1;198	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3302	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2981	138.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2264	2266	GGC	195;196;196	G;G;C	195;196;196	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3302	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2981	138.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2282	2284	CCG	204;203;201	C,T,G;C;G	202,1,1;203;201	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	4648	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	3414	169.6	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1758	1760	CTG	186;186;185	C,A;T,G;G	185,1;185,1;185	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2046	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2233	114.4	0	.	p	.	0	S22G	NONSYN	64	66	AGC	592	594	GGC	128;130;131	G;G;C	128;130;131	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2046	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2233	114.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	774	774	C	189	C,A	188,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	236	porB1a	984	155	92.9	porB1a.l15.c17.ctg.1	155	46.8	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	34;35;37	T;T,G;A	34;34,1;37	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	236	porB1a	984	155	92.9	porB1a.l15.c17.ctg.1	155	46.8	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	58;58;58	C;A;T	58;58;58	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	236	porB1a	984	155	92.9	porB1a.l15.c17.ctg.1	155	46.8	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	58;58;58	A;G,T;T	58;57,1;58	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	236	porB1a	984	155	92.9	porB1a.l15.c17.ctg.1	155	46.8	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	58;58;58	T;A;C	58;58;58	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2412	porB1b	1035	1035	98.57	porB1b.l15.c30.ctg.1	1639	178.8	0	.	p	.	0	G46S	NONSYN	136	138	GGC	584	586	AGC	200;199;195	A,G;G;C	199,1;199;195	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2412	porB1b	1035	1035	98.57	porB1b.l15.c30.ctg.1	1639	178.8	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1079	1079	T	201	T,A	200,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2412	porB1b	1035	1035	98.57	porB1b.l15.c30.ctg.1	1639	178.8	1	SNP	p	G120K	0	.	.	358	360	GGT	806	808	GGT	212;210;210	G,T;G;T,A	210,2;210;209,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2412	porB1b	1035	1035	98.57	porB1b.l15.c30.ctg.1	1639	178.8	1	SNP	p	A121D	0	.	.	361	363	GCC	809	811	GCC	208;210;212	G;C,T,A;C,A	208;207,1,2;211,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2412	porB1b	1035	1035	98.57	porB1b.l15.c30.ctg.1	1639	178.8	1	SNP	p	A121N	0	.	.	361	363	GCC	809	811	GCC	208;210;212	G;C,T,A;C,A	208;207,1,2;211,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	7994	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5505	181.2	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2331	2333	CAT	193;196;198	C;A;T	193;196;198	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1128	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1441	97.4	1	SNP	p	V57M	1	.	.	169	171	ATG	726	728	ATG	205;205;205	A,G;T,C;G,A	204,1;204,1;204,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
